355 related articles for article (PubMed ID: 31837445)
1. Childhood GPA, EGPA, and MPA.
Jariwala M; Laxer RM
Clin Immunol; 2020 Feb; 211():108325. PubMed ID: 31837445
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Beketova TV
Ter Arkh; 2018 May; 90(5):13-22. PubMed ID: 30701885
[TBL] [Abstract][Full Text] [Related]
3. Primary Vasculitis in Childhood: GPA and MPA in Childhood.
Jariwala MP; Laxer RM
Front Pediatr; 2018; 6():226. PubMed ID: 30167431
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
[TBL] [Abstract][Full Text] [Related]
5. [Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: advances in pathogenesis and treatment].
Silva F; Cisternas M
Rev Med Chil; 2013 Jun; 141(6):765-73. PubMed ID: 24121580
[TBL] [Abstract][Full Text] [Related]
6. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.
Sada KE; Yamamura M; Harigai M; Fujii T; Dobashi H; Takasaki Y; Ito S; Yamada H; Wada T; Hirahashi J; Arimura Y; Makino H;
Arthritis Res Ther; 2014 Apr; 16(2):R101. PubMed ID: 24758294
[TBL] [Abstract][Full Text] [Related]
7. The role of rituximab in the treatment of ANCA-associated vasculitides (AAV).
Daikeler T; Kistler AD; Martin PY; Vogt B; Huynh-Do U
Swiss Med Wkly; 2015; 145():w14103. PubMed ID: 25658140
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey.
Pamuk ÖN; Dönmez S; Calayır GB; Pamuk GE
Clin Rheumatol; 2016 Aug; 35(8):2063-2071. PubMed ID: 26992904
[TBL] [Abstract][Full Text] [Related]
9. Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway.
Nilsen AT; Karlsen C; Bakland G; Watts R; Luqmani R; Koldingsnes W
Rheumatology (Oxford); 2020 Sep; 59(9):2316-2324. PubMed ID: 31859355
[TBL] [Abstract][Full Text] [Related]
10. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.
Cornec D; Cornec-Le Gall E; Fervenza FC; Specks U
Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484
[TBL] [Abstract][Full Text] [Related]
11. Environmental factors influencing the risk of ANCA-associated vasculitis.
Zhao WM; Wang ZJ; Shi R; Zhu YY; Zhang S; Wang RF; Wang DG
Front Immunol; 2022; 13():991256. PubMed ID: 36119110
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.
Hazebroek MR; Kemna MJ; Schalla S; Sanders-van Wijk S; Gerretsen SC; Dennert R; Merken J; Kuznetsova T; Staessen JA; Brunner-La Rocca HP; van Paassen P; Cohen Tervaert JW; Heymans S
Int J Cardiol; 2015 Nov; 199():170-9. PubMed ID: 26209947
[TBL] [Abstract][Full Text] [Related]
13. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
[TBL] [Abstract][Full Text] [Related]
14. Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
Lee JJY; Alsaleem A; Chiang GPK; Limenis E; Sontichai W; Yeung RSM; Akikusa J; Laxer RM
Pediatr Rheumatol Online J; 2019 Jun; 17(1):31. PubMed ID: 31242923
[TBL] [Abstract][Full Text] [Related]
15. Muscle biopsy in anti-neutrophil cytoplasmic antibody-associated vasculitis: diagnostic yield depends on anti-neutrophil cytoplasmic antibody type, sex and neutrophil count.
Lacou M; Leroy M; Le Lan N; Toquet C; Espitia-Thibault A; Graveleau J; Masseau A; Agard C; Volteau C; Mussini JM; Hamidou M; Néel A
Rheumatology (Oxford); 2021 Feb; 60(2):699-707. PubMed ID: 32789447
[TBL] [Abstract][Full Text] [Related]
16. [Anca-associated vasculitides in elderly people].
Jeleniewicz R
Wiad Lek; 2019; 72(9 cz 1):1691-1696. PubMed ID: 31586985
[TBL] [Abstract][Full Text] [Related]
17. ANCA associated vasculitis in patients from Saudi Arabia.
Al Arfaj AS; Khalil N
Pak J Med Sci; 2018; 34(1):88-93. PubMed ID: 29643885
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
[TBL] [Abstract][Full Text] [Related]
19. ANCA-Associated Vasculitis: Core Curriculum 2020.
Geetha D; Jefferson JA
Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
[TBL] [Abstract][Full Text] [Related]
20. Vasculitis for the internist: focus on ANCA-associated vasculitis.
Chaigne B; Guillevin L
Intern Emerg Med; 2017 Aug; 12(5):577-585. PubMed ID: 28623488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
